ICPRE2023 INTERPROFESSIONAL CLINICAL DEBATE (IPCD) COMPETITION Name of the leading participant Gender of the leading participant Male Female Organization Email Mobile City, Region Country Background Healthcare professional Scientist/Researcher Student Other Registration Type Individual Group (if you choose group, please list all the names of your group under "Group List") List the first coparticipant of your group List the second coparticipant of your group Suggested Group Name The topic you choose to debate Experts debate on the association of SGLT2I and amputations as data emerge. GLP-1 receptor agonists or SGLT2 inhibitors as first-line therapy. Obesity vs glycemic control as a primary target for treating T2DM; ‘Inevitable’ or not? Telehealth in diabetes vs current practice or high efficiency vs the personal connection: experts debate the future of telemedicine. Using inhaled insulin vs. injectable insulin/ oral hypoglycemics to manage DM. Agreement I agree to the terms and conditions of ICPRE2023 IPCD Competition Send
